FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

VESSEY RUPERT
2. Issuer Name and Ticker or Trading Symbol

BRISTOL MYERS SQUIBB CO [ BMY ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
EVP, Research & Early Dev.
(Last)          (First)          (Middle)

430 E. 29TH STREET, 14TH FLOOR
3. Date of Earliest Transaction (MM/DD/YYYY)

11/19/2020
(Street)

NEW YORK, NY 10016
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $0.10 par value 11/19/2020  S  10579 (1)D$61.25 (1)46142 D  
Common Stock, $0.10 par value 11/19/2020  M  14515 A$54.94 60657 D  
Common Stock, $0.10 par value 11/19/2020  M  12233 A$54.29 72890 D  
Common Stock, $0.10 par value 11/19/2020  M  8489 A$44.70 81379 D  
Common Stock, $0.10 par value 11/19/2020  M  8489 A$47.81 89868 D  
Common Stock, $0.10 par value 11/19/2020  M  8487 A$38.41 98355 D  
Common Stock, $0.10 par value 11/19/2020  S  47012 (2)D$61.31 (2)51343 D  
Common Stock, $0.10 par value         613 (3)I 401(k) 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Option (right to buy) $54.94 11/19/2020  M     14515   (4)10/31/2026 Common Stock, $0.10 par value 14515.0 $0 0 D  
Option (right to buy) $54.29 11/19/2020  M     12233   (4)10/30/2027 Common Stock, $0.10 par value 12233.0 $0 12233 D  
Option (right to buy) $44.7 11/19/2020  M     8489   (4)5/8/2028 Common Stock, $0.10 par value 8489.0 $0 16980 D  
Option (right to buy) $47.81 11/19/2020  M     8489   (4)7/30/2028 Common Stock, $0.10 par value 8489.0 $0 16980 D  
Option (right to buy) $38.41 11/19/2020  M     8487   (4)10/29/2028 Common Stock, $0.10 par value 8487.0 $0 16981 D  

Explanation of Responses:
(1) The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $61.19 to $61.29, inclusive. The reporting person undertakes to provide the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
(2) 47,012 of the shares sold were to cover the exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $61.21 to $61.36, inclusive. The reporting person undertakes to provide the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
(3) Based on recent 401(k) plan statement.
(4) All of the shares are currently exercisable.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
VESSEY RUPERT
430 E. 29TH STREET
14TH FLOOR
NEW YORK, NY 10016


EVP, Research & Early Dev.

Signatures
/s/ Lisa A. Atkins, attorney-in-fact for Rupert Vessey11/23/2020
**Signature of Reporting PersonDate

Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Bristol Myers Squibb Charts.
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Bristol Myers Squibb Charts.